Fine mapping of GWAS signals to identify genetic markers of the plasma triglyceride response to an omega-3 fatty acid supplementation

Vallée Marcotte, Bastien, Guénard, Frédéric, Lemieux, Simone, Couture, Patrick, Rudkowska, Iwona, Calder, Philip C, Minihane, Anne-Marie and Vohl, MC (2019) Fine mapping of GWAS signals to identify genetic markers of the plasma triglyceride response to an omega-3 fatty acid supplementation. The American Journal of Clinical Nutrition, 109 (1). pp. 176-185. ISSN 0002-9165

[img] PDF (FIGURE 2) - Submitted Version
Restricted to Repository staff only until 08 January 2020.

Download (83kB) | Request a copy
    [img] PDF (FIGURE 4) - Submitted Version
    Restricted to Repository staff only until 08 January 2020.

    Download (8kB) | Request a copy
      [img] PDF (FIGURE 1) - Submitted Version
      Restricted to Repository staff only until 08 January 2020.

      Download (451kB) | Request a copy
        [img] PDF (FIGURE 3) - Submitted Version
        Restricted to Repository staff only until 08 January 2020.

        Download (7kB) | Request a copy
          [img] PDF (revised_article_1_postJuanVrai_FINAL_black) - Submitted Version
          Restricted to Repository staff only until 08 January 2020.

          Download (772kB) | Request a copy

            Abstract

            Background: Using a genome-wide association study (GWAS) approach, our group previously computed a genetic risk score (GRS) from single nucleotide polymorphisms (SNPs) of ten loci which affect the plasma triglyceride (TG) response to an omega-3 (n-3) fatty acid (FA) supplementation. Objective: The objective was to compute a novel and more refined GRS using fine mapping to include a large number of genetic variants. Design: A total of 208 participants of the Fatty Acid Sensor (FAS) study received 5g of fish oil per day, containing 1.9–2.2g of eicosapentanoic acid and 1.1g of docosahexanoic acid, for six weeks. Plasma TG levels were measured before and after supplementation. Dense genotyping and genotype imputation were employed to refine mapping around GWAS hits. A GRS was computed by summing the number of at-risk alleles of tagging SNPs. Analyses were replicated in samples of the FINGEN study. Results: A total of 31 tagging SNPs associated with the TG response were used for GRS calculation in the FAS study. In a general linear model adjusted for age, sex and body mass index, the GRS explained 49.73% of TG response variance (p < 0.0001). Non-responders to the n-3 FA supplementation had a higher GRS than responders. In the FINGEN replication study, the GRS explained 3.67% of TG response variance (p = 0.0006). Conclusion: Fine mapping proved to be effective to refine the previous GRS. Carrying increasing numbers of at-risk alleles of 31 SNPs confers a higher risk of being non-responsive to n-3 FA. The genetic profile therefore appears to be an important determinant of the plasma TG response to an n-3 FA supplementation and could be used to target those most likely to gain clinical benefit.

            Item Type: Article
            Uncontrolled Keywords: genetic risk score,plasma lipid levels,omega-3 fatty acids,genome-wide association study,nutrigenetics,gene-diet interactions
            Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
            Depositing User: LivePure Connector
            Date Deposited: 14 Jan 2019 13:30
            Last Modified: 09 Apr 2019 14:04
            URI: https://ueaeprints.uea.ac.uk/id/eprint/69567
            DOI: 10.1093/ajcn/nqy298

            Actions (login required)

            View Item